Old Web
English
Sign In
Acemap
>
authorDetail
>
Kiyotaka Yamazaki
Kiyotaka Yamazaki
Novartis
cost savings
Cancer research
budget impact
Pharmacotherapy
Population study
1
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Budget Impact Analysis of Treatment-Free Remission in Nilotinib Treated Japanese Chronic Myeloid Leukemia Patients.
2020
Cancer Science
Kiyotaka Yamazaki
Naohito Inagaki
Daniel Moldaver
Ricardo Viana
Shinya Kimura
Show All
Source
Cite
Save
Citations (4)
1